oral glp-1 for weight loss Medication Helps Patients Maintain | Newsroom crave less glp-1 oral dosage for weight

Implications from the study included that 8.9% of diabetic patients and 6.7% of obese patients on GLP-1 developed NAION compared to 1.8% and 0.8% respectively in those using other medications

However, it's also important to be aware that if the medication is stopped, this food noise can return, sometimes intensely

Instead, it travels through the gut-brain axis via the vagus nerve

GLP-1 receptor signaling increases PCSK1 and cell features in human cells

10.1016/j.physbeh.2012.02.017 Physiol

The study involved 411 adult patients with T2DM and was designed as a randomized, double-blind, placebo-controlled trial where patients received varying doses of danuglipron or a placebo